ASTRAZENECA PHARMA INDIA
|
The Current P/S Ratio of ASTRAZENECA PHARMA INDIA is 8.13.
| Share Price | ₹7,905.7 | Aug 12,2026 |
| Market Cap | ₹19,764.3 Cr | |
| Sales-TTM | ₹2,432.1 Cr | TTM-Standalone Results |
| Price/Sales | 8.13x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ASTRAZENECA PHARMA INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹19,764.3 Cr] as on Aug 12,2026
(/) Sales [ ₹2,432.1 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 8.13x ]
Thus, for ASTRAZENECA PHARMA INDIA , the investors are currently willing to pay '8.13 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ASTRAZENECA PHARMA INDIA !
The chart below summarizes the trend in P/S Ratio of ASTRAZENECA PHARMA INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of ASTRAZENECA PHARMA INDIA
PS Ratio Performance Analysis for ASTRAZENECA PHARMA INDIA
- ASTRAZENECA PHARMA INDIA 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 9.47x.
- ASTRAZENECA PHARMA INDIA 's operated at median p/e ratio of 8.52x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ASTRAZENECA PHARMA INDIA 's p/e ratio peaked in Mar2025 at 12.54x.
- ASTRAZENECA PHARMA INDIA 's p/e ratio hit its five-year low in Mar2022 of 7.93x.
How does ASTRAZENECA PHARMA INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ASTRAZENECA PHARMA INDIA | 2,432.1 | 8.13 | 19,764.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.75 | 464,271.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 20.20 | 226,843.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.83 | 186,000.0 |
| CIPLA LTD | 28,324.4 | 4.17 | 118,072.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.01 | 100,073.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.79 | 100,137.0 |
| LUPIN LTD | 29,966.6 | 3.46 | 103,550.0 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.20 | 120,099.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.74 | 95,797.5 |
| LAURUS LABS LTD | 7,269.6 | 13.68 | 99,474.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ASTRAZENECA PHARMA INDIA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.74x |
| Max industry PS | 20.20x |
| Median industry PS | 6.79x |
| Average industry PS | 7.82x |
You may also like the below Video Courses